North America COVID-19 Diagnostics Market Report and Forecast 2024-2032

North America COVID-19 Diagnostics Market Outlook

The North America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed nearly 390 million tests for COVID-19 as of March 2021.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Number of COVID-19 Cases to Propel the Growth of the COVID-19 Diagnostics Industry in the Short Term

Ever since the outbreak of the COVID-19 pandemic, the demand for COVID-19 diagnostic kits has exponentially risen in North America because of the widespread need for testing within the region. The demand for the diagnostic kits have, especially, witnessed a substantial rise in the United States of America due to the significant and rising number of active cases in the country. The highest number of cases in the world have been registered in the United States of America as of March 2021, and there has been a great need for testing and vaccination in the country. To prevent the spread of the virus further, the country has also implemented measures to test travellers entering the country and those travelling within the country, thus, further contributing to the growth of the COVID-19 diagnostics industry in North America.

In the short term, the demand for COVID-19 diagnostics is expected to rise rapidly in the North America region, but in the long term, the market is expected to shrink as vaccines for COVID-19 enter the market and people develop antibodies.

COVID-19 Diagnostics: Market Segmentation

COVID-19 diagnostics are used to detect if a person is COVID-19 positive, their infection level, or if they have developed COVID-19 antibodies. They may involve tests of different types, such as RT PCR test, rapid antigen test, and others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The market for COVID-19 diagnostics may be divided by test type into:

• PCR Test
• Antigen Test
• Antibody Test
• Others

The market can be segmented on the basis of product into:

• RT-PCR Assay Kits
• Immunoassay Test Strips
• Others

The industry can be differentiated by end use into:

• Hospitals 
• Diagnostic Centres and Clinics
• Laboratories
• Others

The market can be further segmented by sample type into:

• Nasopharyngeal Swab
• Oropharyngeal (OP) Swab
• Nasal Swab
• Blood Test
• Others

By business model, the industry can be divided into:

• Point-of-Care (PoC) Testing
• Non-Point-of-Care (PoC) Testing

The regional markets for the COVID-19 diagnostics industry in North America can be divided into Canada and the United States of America.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Favourable Governmental Regulations Bolstering the Market Growth in North America

The rising number of novel coronavirus cases in the North America region, especially in the United States of America, has led to a massive demand for testing kits. The portability of these testing kits has allowed more people to be tested in a large number, and it is expected that the demand for these will continue to grow, at least in the short term.

Since there have been multiple waves observed in the prevalence of the transmission of COVID-19, along with mutations of the virus into different variants, the same population has been tested multiple times, causing a consistent demand for the diagnostic tools. Governments in the North America region have relaxed regulations for these diagnostic kits in view of the emergency. Such measures have catalysed the growth of the COVID-19 diagnostics market. There has also been continuous research and development sponsored by both the government and private players, which has helped to create more effective testing kits, with fewer occurrences of false positive reports, further propelling the market ahead.

Key Industry Players in the North America COVID-19 Diagnostics Market

The report gives a detailed analysis of the following key players in the North America COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Abbott Laboratories
• Becton, Dickinson and Company 
• LuminUltra Technologies Ltd.
• Co-Diagnostics, Inc 
• CTK Biotech, Inc.
• Thermo Fisher Scientific
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report